The role of lipid management in diabetes.
This article discusses the role of lipid management in diabetes.
Ganda
Om P
OP
Joslin Diabetes Center, Department of Medicine, Harvard Medical School, One Joslin Place, # 242, Boston, MA 02115, USA. om.ganda@joslin.harvard.edu
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000069059:Atorvastatin; D003920:Diabetes Mellitus / Q000097:blood*; D003925:Diabetic Angiopathies / Q000097:blood / Q000517:prevention & control*; D015248:Gemfibrozil / Q000627:therapeutic use; D006538:Heptanoic Acids / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000517:prevention & control*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008075:Lipoproteins, HDL / Q000097:blood; D011758:Pyrroles / Q000627:therapeutic use; D019821:Simvastatin / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D011758:Pyrroles; D014280:Triglycerides; D000069059:Atorvastatin; D019821:Simvastatin; D015248:Gemfibrozil